Evelina Rubinchik

Evelina Rubinchik is a highly experienced product development consultant with over 13 years of experience in the field of nonclinical pharmacology and toxicology. Evelina has worked with a number of biotechnology companies, helping them to develop and implement strategies for toxicology and pharmacology testing, as well as GLP compliance evaluations. In their role as Senior Director at BioWest Therapeutics Inc, they were responsible for product development and project management. At MIGENIX Inc., they served as Director of Pharmacology and Nonclinical Development, overseeing a team of scientists working on a variety of projects. Evelina has also worked as a Project Leader in Nonclinical Toxicology and Pharmacology at Micrologix Biotech Inc., where they were responsible for the development and implementation of nonclinical studies. In their current role as Product Development Consultant at Trethera, they are responsible for the development and implementation of nonclinical strategies for toxicology and pharmacology testing, as well as GLP compliance evaluations.

Evelina Rubinchik works with colleagues in product development, clinical operations, and clinical pharmacology on the development and regulation of new products.